Cargando...
Engineering Nanoparticles for Targeted Delivery of Nucleic Acid Therapeutics in Tumor
In the past 10 years, with the increase of investment in clinical nano-gene therapy, there are many trials that have been discontinued due to poor efficacy and serious side effects. Therefore, it is particularly important to design a suitable gene delivery system. In this paper, we introduce the app...
Gardado en:
| Publicado en: | Mol Ther Methods Clin Dev |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
American Society of Gene & Cell Therapy
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6197778/ https://ncbi.nlm.nih.gov/pubmed/30364598 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtm.2018.09.002 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|